FHEA Exam 2 | Verified Exam Questions and Answers | Latest Updated
Study Material 2026
Question:
1. Which of the following is not considered an
acute-phase protein?
Answer:
C. Hemoglobin
A. C-reactive protein
B. Haptoglobin
C. Hemoglobin
D. Fibrinogen
Question:
2. All of the following are inflammation-associated cy-
tokines except:
Answer:
B. TSH.
A. Interleukin-6.
B. TSH.
C. Interleukin-8.
D. TNF.
Question:
3. Which of the following laboratory findings is most
likely present in an individual with moderate-to-severe >5 mg/L
COVID-19?
Answer:
D. C-reactive protein (CRP)
A. Lymphocytosis
B. Decreased prothrombin time
C. Decreased lactate dehydrogenase (LDH)
D. C-reactive protein (CRP) >5 mg/L
Question:
4. Of the following adults, who is most likely to have the A. A 65-year-old woman
,Answer:
highest ESR when healthy?
A. A 65-year-old woman
B. A 32-year-old man
C. A 45-year-old man
D. A 40-year-old woman
Question:
5. The erythrocyte sedimentation rate can be falsely de- A. Anisocytosis.
Answer:
creased by the presence of:
A. Anisocytosis.
B. Anemia
C. Leukopenia.
D. Macrocytosis.
Question:
6. Which of the following is most likely to be present at
the time of rheumatoid arthritis diagnosis?
Answer:
D. Rheumatoid factor
A. Antinuclear antibodies
B. Neutropenia
C. Thrombocytopenia
D. Rheumatoid factor
Question:
7. Which of the following findings is associated with ear- C. Low RF, positive
ly or preclinical RA?
Answer:
anti-CCP antibody
A. High RF, positive anti-CCP antibody
B. High RF, negative anti-CCP antibody
C. Low RF, positive anti-CCP antibody
D. Low RF, negative anti-CCP antibody
,Question:
8. A 45-year-old man with hypertension, type 2 diabetes C. Hydralazine
Answer:
mellitus and dyslipidemia presents with suspected
drug-induced lupus erythematosus (DILE). Of the fol-
lowing medications he is taking, which is most likely
to be implicated in DILE?
A. Trandolapril
B. Atenolol
C. Hydralazine
D. Clonidine
Question:
9. In a person with drug-induced lupus erythematosus,
which of the following is most likely to be absent?
Answer:
C. Diffuse maculopapular
rash
A. Recurrent fever
B. Muscle or joint pain
C. Diffuse maculopapular rash
D. Serositis
Question:
10. Which of the following best describes the clinical
and laboratory abnormal-
A. Progressive nephritis even with the discontinuation of the offending medica-
of the offending medication
B. Resolution of symptoms and laboratory abnormal-
ities upon discontinuation of the offending medica-
tion
C. Resolution of symptoms with continued laboratory
abnormalities upon discontinuation of the offending
medication
D. Continued symptoms with resolution of laboratory
abnormalities upon discontinuation of the offending
medication
Answer:
B. Resolution of symptoms
, course of drug-induced lupus erythematosus?
ities upon discontinuation
tion
Question:
11. Anemia of chronic disease is present in approximately D. 80%
Answer:
of individuals when initially diagnosed with RA.
A. 20%
B. 40%
C. 60%
D. 80%
Question:
12. In which of the following conditions is the ANA test
most likely to be positive?
Answer:
D. Systemic lupus erythe-
matosus
A. Sjögren's syndrome
B. Graves' disease
C. Dermatomyositis
D. Systemic lupus erythematosus
Question:
13. Which of the following best indicates an evolving ane- C. Elevated RDW
Answer:
mia?
A. Low MCV
B. Elevated MCV
C. Elevated RDW
D. Low MCHC
Question:
14. Which of the following will most likely result in a nor- B. Presence of a chronic
mocytic, normochromic anemia?
Study Material 2026
Question:
1. Which of the following is not considered an
acute-phase protein?
Answer:
C. Hemoglobin
A. C-reactive protein
B. Haptoglobin
C. Hemoglobin
D. Fibrinogen
Question:
2. All of the following are inflammation-associated cy-
tokines except:
Answer:
B. TSH.
A. Interleukin-6.
B. TSH.
C. Interleukin-8.
D. TNF.
Question:
3. Which of the following laboratory findings is most
likely present in an individual with moderate-to-severe >5 mg/L
COVID-19?
Answer:
D. C-reactive protein (CRP)
A. Lymphocytosis
B. Decreased prothrombin time
C. Decreased lactate dehydrogenase (LDH)
D. C-reactive protein (CRP) >5 mg/L
Question:
4. Of the following adults, who is most likely to have the A. A 65-year-old woman
,Answer:
highest ESR when healthy?
A. A 65-year-old woman
B. A 32-year-old man
C. A 45-year-old man
D. A 40-year-old woman
Question:
5. The erythrocyte sedimentation rate can be falsely de- A. Anisocytosis.
Answer:
creased by the presence of:
A. Anisocytosis.
B. Anemia
C. Leukopenia.
D. Macrocytosis.
Question:
6. Which of the following is most likely to be present at
the time of rheumatoid arthritis diagnosis?
Answer:
D. Rheumatoid factor
A. Antinuclear antibodies
B. Neutropenia
C. Thrombocytopenia
D. Rheumatoid factor
Question:
7. Which of the following findings is associated with ear- C. Low RF, positive
ly or preclinical RA?
Answer:
anti-CCP antibody
A. High RF, positive anti-CCP antibody
B. High RF, negative anti-CCP antibody
C. Low RF, positive anti-CCP antibody
D. Low RF, negative anti-CCP antibody
,Question:
8. A 45-year-old man with hypertension, type 2 diabetes C. Hydralazine
Answer:
mellitus and dyslipidemia presents with suspected
drug-induced lupus erythematosus (DILE). Of the fol-
lowing medications he is taking, which is most likely
to be implicated in DILE?
A. Trandolapril
B. Atenolol
C. Hydralazine
D. Clonidine
Question:
9. In a person with drug-induced lupus erythematosus,
which of the following is most likely to be absent?
Answer:
C. Diffuse maculopapular
rash
A. Recurrent fever
B. Muscle or joint pain
C. Diffuse maculopapular rash
D. Serositis
Question:
10. Which of the following best describes the clinical
and laboratory abnormal-
A. Progressive nephritis even with the discontinuation of the offending medica-
of the offending medication
B. Resolution of symptoms and laboratory abnormal-
ities upon discontinuation of the offending medica-
tion
C. Resolution of symptoms with continued laboratory
abnormalities upon discontinuation of the offending
medication
D. Continued symptoms with resolution of laboratory
abnormalities upon discontinuation of the offending
medication
Answer:
B. Resolution of symptoms
, course of drug-induced lupus erythematosus?
ities upon discontinuation
tion
Question:
11. Anemia of chronic disease is present in approximately D. 80%
Answer:
of individuals when initially diagnosed with RA.
A. 20%
B. 40%
C. 60%
D. 80%
Question:
12. In which of the following conditions is the ANA test
most likely to be positive?
Answer:
D. Systemic lupus erythe-
matosus
A. Sjögren's syndrome
B. Graves' disease
C. Dermatomyositis
D. Systemic lupus erythematosus
Question:
13. Which of the following best indicates an evolving ane- C. Elevated RDW
Answer:
mia?
A. Low MCV
B. Elevated MCV
C. Elevated RDW
D. Low MCHC
Question:
14. Which of the following will most likely result in a nor- B. Presence of a chronic
mocytic, normochromic anemia?